NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Publication
, Journal Article
Benson, AB; D'Angelica, MI; Abrams, T; Abbott, DE; Ahmed, A; Anaya, DA; Anders, R; Are, C; Bachini, M; Binder, D; Borad, M; Bowlus, C; Kim, R ...
Published in: J Natl Compr Canc Netw
July 2023
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
July 2023
Volume
21
Issue
7
Start / End Page
694 / 704
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Liver Neoplasms
- Humans
- Gallbladder Neoplasms
- Cholangiocarcinoma
- Biliary Tract Neoplasms
- Bile Ducts, Intrahepatic
- Bile Duct Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Benson, A. B., D’Angelica, M. I., Abrams, T., Abbott, D. E., Ahmed, A., Anaya, D. A., … Hochstetler, C. (2023). NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. J Natl Compr Canc Netw, 21(7), 694–704. https://doi.org/10.6004/jnccn.2023.0035
Benson, Al B., Michael I. D’Angelica, Thomas Abrams, Daniel E. Abbott, Aijaz Ahmed, Daniel A. Anaya, Robert Anders, et al. “NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.” J Natl Compr Canc Netw 21, no. 7 (July 2023): 694–704. https://doi.org/10.6004/jnccn.2023.0035.
Benson AB, D’Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, et al. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. J Natl Compr Canc Netw. 2023 Jul;21(7):694–704.
Benson, Al B., et al. “NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.” J Natl Compr Canc Netw, vol. 21, no. 7, July 2023, pp. 694–704. Pubmed, doi:10.6004/jnccn.2023.0035.
Benson AB, D’Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Binder D, Borad M, Bowlus C, Brown D, Burgoyne A, Castellanos J, Chahal P, Cloyd J, Covey AM, Glazer ES, Hawkins WG, Iyer R, Jacob R, Jennings L, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Ronnekleiv-Kelly S, Sahai V, Singh G, Stein S, Turk A, Vauthey J-N, Venook AP, Yopp A, McMillian N, Schonfeld R, Hochstetler C. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. J Natl Compr Canc Netw. 2023 Jul;21(7):694–704.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
July 2023
Volume
21
Issue
7
Start / End Page
694 / 704
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Liver Neoplasms
- Humans
- Gallbladder Neoplasms
- Cholangiocarcinoma
- Biliary Tract Neoplasms
- Bile Ducts, Intrahepatic
- Bile Duct Neoplasms
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis